CS Medica A/S reported earnings results for the fourth quarter and full year ended September 30, 2024. For the fourth quarter, the company reported sales was DKK 3.87 million compared to DKK 0.072992 million a year ago. Net loss was DKK 1.06 million compared to DKK 3.71 million a year ago. Basic loss per share from continuing operations was DKK 0.06 compared to DKK 0.3 a year ago.
For the full year, sales was DKK 8.46 million compared to DKK 1.07 million a year ago. Net loss was DKK 9.65 million compared to DKK 14.51 million a year ago. Basic loss per share from continuing operations was DKK 0.56 compared to DKK 1.18 a year ago.